U
Uniqure NV (QURE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$21.88
-1.93 (-8.11%)
Market Cap: $1.67B
Last updated: Nov 17, 2026 at 11:06 AM ET
Uniqure NV (QURE) Valuation Multiples
Uniqure NV (QURE) trades at 75.8x sales and 5.2x book value. Its P/S of 75.8x is above its 5-year median of 14.2x. Its forward P/E is 27.9x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 27.9x |
| Price to sales | 75.8x |
| Price to book | 5.2x |
| PEG | N/A |
| FCF yield | -12.6% |
Historical Medians
Against its 10-year medians, its P/S is 113.5% above 35.5x and its P/B is 10.3% below 5.8x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 75.8x | 14.2x | 35.5x |
| P/B | 5.2x | 2.2x | 5.8x |
Valuation History
Over the 10 year ends shown, its P/S ranged from 1.8x in 2021 to 383.5x in 2019.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $23.93 | N/A | 83.8x | 6.9x |
| 2024 | $17.66 | N/A | 31.6x | N/A |
| 2023 | $6.77 | N/A | 20.4x | 1.6x |
| 2022 | $22.67 | N/A | 10.0x | 2.2x |
| 2021 | $20.74 | 3.5x | 1.8x | 1.6x |
| 2020 | $36.13 | N/A | 42.8x | 6.6x |
| 2019 | $71.66 | N/A | 383.5x | 8.9x |
| 2018 | $28.82 | N/A | 89.1x | 5.7x |
| 2017 | $19.59 | N/A | 38.6x | 5.9x |
| 2016 | $5.60 | N/A | 5.6x | 2.2x |
Frequently Asked Questions About QURE
What is QURE's forward P/E ratio?
Uniqure NV has a forward P/E ratio of 27.9x.
What is QURE's price to sales ratio?
Uniqure NV has a price to sales ratio of 75.8x.
QURE pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors